In-room imaging and MR planning
LDR brachytherapy only for low-risk patients
Intermediate-risk (T2b or Gleason 7 or PSA 10 – 20 ng/ml)
Low-risk (T1c-2a & Gleason ≤ 6 & PSA ≤ 10 ng/ml)
D’Amico A. V. et al. JAMA 1998.
Made with FlippingBook - professional solution for displaying marketing and sales documents online